Streetbeat News

TNON

Tenon Medical, Inc.

https://www.tenonmed.com

Industry

Medical - Devices

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Open

4.29

Mkt cap

13M

Volume

246M

High

5.85

P/E Ratio

0.01

52-wk high

15.79

Low

3.27

Div yield

N/A

52-wk low

0.91

Tenon Medical (NASDAQ:TNON) reported Q3 earnings with a loss of $(1.46) per share, outperforming the $(2.80) estimate, marking a 48.23% improvement from the previous year. However, sales of $944.00K fell short of the $1.07M estimate, despite being a 353.85% increase from the same period last year.

Portfolio Pulse from totan@benzinga.com

November 14, 2023 | 9:31 pm

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Tenax Therapeutics (TENX) saw a massive increase of 319.0% to $0.65 with an exceptionally high trading volume. Tivic Health Systems (TIVC) rose by 68.89% following their Q3 earnings release. ZyVersa Therapeutics (ZVSA), INVO Bioscience (INVO), MSP Recovery (LIFW), and Tenon Medical (TNON) also saw gains ranging from 18.27% to 32.88%. On the downside, TC BioPharm (TCBP) plummeted by 90.0%, Aclaris Therapeutics (ACRS) dropped by 86.77%, and other stocks like Mainz Biomed (MYNZ), Verve Therapeutics (VERV), TRACON Pharma (TCON), and Alector (ALEC) experienced declines between 16.58% and 45.54%.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 5:31 pm

The article lists a number of companies scheduled to report their earnings on November 14, 2023. It includes their expected quarterly results, with some companies anticipated to report profits per share and others expected to report losses. The revenues for each company are also provided, giving investors insights into the financial performance of these companies for the upcoming earnings announcements.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:23 pm

During Monday's intraday session, several healthcare stocks experienced significant movements. Tenax Therapeutics (TENX) saw a massive surge of 322.1%, while Tivic Health Systems (TIVC) and ZyVersa Therapeutics (ZVSA) also posted substantial gains. On the downside, TC BioPharm (TCBP), Aclaris Therapeutics (ACRS), and Mainz Biomed (MYNZ) faced steep declines. Verve Therapeutics (VERV), TRACON Pharma (TCON), and Alector (ALEC) also dropped notably, with recent Q3 earnings reports potentially influencing their stock performance.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 5:31 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Heart Test Laboratories, Tenon Medical, Personalis, Cyclo Therapeutics, Viracta Therapeutics, and Senti Biosciences saw their stocks rise, with Heart Test Laboratories leading the gainers with a 60.5% increase. On the other hand, Durect, Establishment Labs Hldgs, Maravai LifeSciences, Panbela Therapeutics, PaxMedica, and Ontrak saw their stocks decline, with Durect leading the losers with a 76.4% decrease.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 5:31 pm

Several stocks are experiencing significant pre-market movements. Senti Biosciences, Tharimmune, TransMedics Group, GSE Systems, Unisys Corporation, Alteryx, Augmedix, Color Star Technology, CF Acquisition Corp. IV, and Tripadvisor reported gains due to various reasons such as strategic collaborations, licensing agreements, better-than-expected Q3 results, and strong FY23 revenue guidance. On the other hand, Ventyx Biosciences, Alto Ingredients, MSP Recovery, Coherus BioSciences, Ameresco, Aura Biosciences, Clover Health Investments, Trevena, Tenon Medical, and NanoString Technologies reported losses due to reasons such as disappointing trial results, mixed Q3 results, and weak quarterly sales.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 1:28 pm

The article lists the stocks that have gained and lost the most in Friday's mid-day session. Among the gainers, Benson Hill, Inc. (BHIL) shares jumped 48.1% to $0.3740, and Seres Therapeutics, Inc. (MCRB) climbed 45.9% to $1.20 after posting a narrower-than-expected quarterly loss. Among the losers, Inseego Corp (INSG) shares fell 35% to $0.3370 after reporting worse-than-expected Q3 results, and Fortinet Inc (FTNT) shares fell 16.8% to $47.92 after reporting mixed Q3 results and issuing FY23 revenue guidance below estimates.

Portfolio Pulse from Lisa Levin

November 03, 2023 | 5:26 pm

US stocks traded higher with the Dow Jones index gaining over 200 points. Real estate shares jumped by 3.1% while energy shares fell by 1%. Tenon Medical, Qurate Retail, and Cooper-Standard Holdings saw significant gains after positive news, while Fox Factory Holding, BILL Holdings, and Inseego Corp. saw significant drops after negative news. The ISM services PMI declined to 51.8 in October, from 53.6 in September.

Portfolio Pulse from Lisa Levin

November 03, 2023 | 4:12 pm

Shares of Tenon Medical Inc (NASDAQ:TNON) surged by 49% after the company announced it has successfully passed a recent FDA Quality System Inspection Technique (QSIT) Level 2 Inspection. The FDA found no violations or objectionable conditions during the inspection. The company's 52-week high is $31.10 and the 52-week low is $0.77.

Portfolio Pulse from Henry Khederian

November 03, 2023 | 2:04 pm

Tenon Medical has announced that it passed an FDA Level 2 Inspection, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:03 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.